174 related articles for article (PubMed ID: 27141014)
1. Serum and urinary endocan levels for bladder cancer diagnosis.
Hu ZD
Ann Clin Biochem; 2016 Nov; 53(6):717. PubMed ID: 27141014
[No Abstract] [Full Text] [Related]
2. The determination of serum and urinary endocan concentrations in patients with bladder cancer.
Laloglu E; Aksoy H; Aksoy Y; Ozkaya F; Akcay F
Ann Clin Biochem; 2016 Nov; 53(6):647-653. PubMed ID: 26748103
[TBL] [Abstract][Full Text] [Related]
3. Endocan is upregulated on tumor vessels in invasive bladder cancer where it mediates VEGF-A-induced angiogenesis.
Roudnicky F; Poyet C; Wild P; Krampitz S; Negrini F; Huggenberger R; Rogler A; Stöhr R; Hartmann A; Provenzano M; Otto VI; Detmar M
Cancer Res; 2013 Feb; 73(3):1097-106. PubMed ID: 23243026
[TBL] [Abstract][Full Text] [Related]
4. Clinical usefulness of the novel marker BLCA-4 for the detection of bladder cancer.
Konety BR; Nguyen TS; Brenes G; Sholder A; Lewis N; Bastacky S; Potter DM; Getzenberg RH
J Urol; 2000 Sep; 164(3 Pt 1):634-9. PubMed ID: 10953114
[TBL] [Abstract][Full Text] [Related]
5. Urine and Serum Exosomes as Novel Biomarkers in Detection of Bladder Cancer.
Elsharkawi F; Elsabah M; Shabayek M; Khaled H
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2219-2224. PubMed ID: 31350988
[TBL] [Abstract][Full Text] [Related]
6. Errors and pitfalls in cytology of the lower urinary tract.
Koss LG
Monogr Pathol; 1997; (39):60-74. PubMed ID: 9249820
[No Abstract] [Full Text] [Related]
7. Clinical significance of CDH13 promoter methylation in serum samples from patients with bladder transitional cell carcinoma.
Lin YL; Sun G; Liu XQ; Li WP; Ma JG
J Int Med Res; 2011; 39(1):179-86. PubMed ID: 21672320
[TBL] [Abstract][Full Text] [Related]
8. Multiplexed quantification of 63 proteins in human urine by multiple reaction monitoring-based mass spectrometry for discovery of potential bladder cancer biomarkers.
Chen YT; Chen HW; Domanski D; Smith DS; Liang KH; Wu CC; Chen CL; Chung T; Chen MC; Chang YS; Parker CE; Borchers CH; Yu JS
J Proteomics; 2012 Jun; 75(12):3529-45. PubMed ID: 22236518
[TBL] [Abstract][Full Text] [Related]
9. New tumor markers in bladder cancer: high promise for lower risk patients?
McNeil C
J Natl Cancer Inst; 1996 Dec; 88(23):1704-5. PubMed ID: 8943997
[No Abstract] [Full Text] [Related]
10. Diagnostic value of urine cytology and urine carcinoembryonic antigen (CEA) level in the distinction between bladder cancer and urinary tract infection.
Gajda M; Tyloch F; Jóźwicki W; Tyloch J; Sujkowska R; Skok Z
Int J Occup Med Environ Health; 1995; 8(2):103-8. PubMed ID: 7582848
[TBL] [Abstract][Full Text] [Related]
11. [Use of marker systems in the treatment of bladder cancer].
Burger M; Vom Dorp F
Urologe A; 2011 Mar; 50(3):303-8. PubMed ID: 21340598
[TBL] [Abstract][Full Text] [Related]
12. Extracellular Vesicles in Bladder Cancer: Biomarkers and Beyond.
Liu YR; Ortiz-Bonilla CJ; Lee YF
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30231589
[TBL] [Abstract][Full Text] [Related]
13. Markers of bladder cancer.
Mostofi FK
J Natl Cancer Inst; 1988 Oct; 80(15):1184. PubMed ID: 3138429
[No Abstract] [Full Text] [Related]
14. Panel of Urinary Diagnostic Markers for Non-Invasive Detection of Primary and Recurrent Urothelial Urinary Bladder Carcinoma.
Soukup V; Kalousová M; Capoun O; Sobotka R; Breyl Z; Pešl M; Zima T; Hanuš T
Urol Int; 2015; 95(1):56-64. PubMed ID: 25662337
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic pitfalls of rare urinary bladder tumors: differential diagnosis of lymphoma-like carcinoma of the bladder--a clinicopathologic study and literature review.
Wronski S; Marszalek A
J Clin Oncol; 2011 Mar; 29(8):e196-9. PubMed ID: 21189383
[No Abstract] [Full Text] [Related]
16. Urinary biomarkers are unreliable for diagnosing bladder cancer, study finds.
Wise J
BMJ; 2015 Oct; 351():h5652. PubMed ID: 26507079
[No Abstract] [Full Text] [Related]
17. Bladder cancer detection and monitoring: assessment of urine- and blood-based marker tests.
Goodison S; Rosser CJ; Urquidi V
Mol Diagn Ther; 2013 Apr; 17(2):71-84. PubMed ID: 23479428
[TBL] [Abstract][Full Text] [Related]
18. [A lively field of controversy].
Böhle A; Jonas D
Urologe A; 2003 Jul; 42(7):901. PubMed ID: 12959080
[No Abstract] [Full Text] [Related]
19. Circulating miRNAs in blood and urine as diagnostic and prognostic biomarkers for bladder cancer: an update in 2017.
Tölle A; Blobel CC; Jung K
Biomark Med; 2018 Jun; 12(6):667-676. PubMed ID: 29896971
[TBL] [Abstract][Full Text] [Related]
20. Identification of urinary Gc-globulin as a novel biomarker for bladder cancer by two-dimensional fluorescent differential gel electrophoresis (2D-DIGE).
Li F; Chen DN; He CW; Zhou Y; Olkkonen VM; He N; Chen W; Wan P; Chen SS; Zhu YT; Lan KJ; Tan WL
J Proteomics; 2012 Dec; 77():225-36. PubMed ID: 22986152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
